BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6177615)

  • 1. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
    Glusa E; Hoffmann A; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):98-106. PubMed ID: 6177615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of benzamidine-type thrombin inhibitors.
    Hauptmann J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
    Phillips DR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):207-15. PubMed ID: 4454040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide].
    Kaiser B; Hauptmann J; Markwardt F
    Pharmazie; 1987 Feb; 42(2):119-21. PubMed ID: 3602050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzamidine derivatives--relationship between antithrombin activity and structure.
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):75-82. PubMed ID: 6177612
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatic tetra-amidines with antiproteolytic activity inhibit platelet aggregation and secretion.
    Milani L; Ferroni R; Zaccarini M; Traniello S
    Thromb Res; 1989 Nov; 56(3):417-24. PubMed ID: 2515612
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthetic inhibitors of serine proteinases. 20. The inhibitory effect of benzo condensed lactam derivatives of benzamidine on trypsin, plasmin and thrombin].
    Walsmann P; Markwardt F; Stürzebecher J; Wagner G; Wunderlich I
    Pharmazie; 1979; 34(3):194-5. PubMed ID: 156372
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of adrenaline-potentiated thrombin-induced reaction of human blood platelets by dihydroergotoxine.
    Barthel W; Hoffmann A; Markwardt F
    Acta Biol Med Ger; 1978; 37(7):1073-9. PubMed ID: 747039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of benzamidine derivatives on platelet function.
    Glusa E; Markwardt F; Hoffmann A
    Acta Univ Carol Med Monogr; 1972; 53():215-9. PubMed ID: 4670730
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ethyl esters of N-amidinobenzoyl aminoacids: inhibitory effect on thrombin, blood coagulation and platelet aggregation].
    Ferroni R; Orlandini P; Guarneri M; Taddeo U; Franzè D; Bardi A
    Farmaco Sci; 1987 Oct; 42(10):709-15. PubMed ID: 3436441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N alpha-arylsulfonyl-omega-amidinophenyl-alpha-aminoalkyl-carboxylic acid amides as specific thrombin inhibitors.
    Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):83-8. PubMed ID: 6177613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of thrombin inhibitors on the thrombin-induced activation of human blood platelets.
    Markwardt F; Hoffmann A; Stürzebecher J
    Haemostasis; 1983; 13(4):227-33. PubMed ID: 6618289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of thrombin-induced platelet aggregation to inhibition by ethanol.
    Marumo M; Wakabayashi I
    Clin Chim Acta; 2009 Apr; 402(1-2):156-9. PubMed ID: 19168042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bovine and human thrombins by derivatives of benzamidine.
    Stürzebecher J; Walsmann P; Voigt B; Wagner G
    Thromb Res; 1984 Dec; 36(5):457-65. PubMed ID: 6523450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatic amidines: inhibitory effect on purified plasma serine proteinases, blood coagulation and platelet aggregation.
    Ferroni R; Menegatti E; Guarneri M; Taddeo U; Ascenzi P; Amiconi G
    Farmaco Sci; 1988 Jan; 43(1):5-13. PubMed ID: 3165070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.